Lidocaine, auricular application

Generic name
Lidocaine, auricular application
Brand name
ATC Code
S02DA01
Compare …

Lidocaine, auricular application

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information is present at this moment.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Earache
  • Auricular
    • 1 month up to 18 years
      • 1 - 2 drop(s)/dose, as required repeat every 2 hours.

      • Contains glycerol. Swelling reduction and pain relief due to water extraction. Only use when the eardrum is intact.

        Bring the eardrops to body temperature first. Before applying the drops, lie the patient on their side; remain lying for 5 minutes after application. The ear can be closed off with a swab.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

OTHER OTOLOGICALS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Reference

  1. Rademaker C.M.A. et al, Geneesmiddelen-Formularium voor Kinderen, 2007

Changes

Therapeutic Drug Monitoring


Overdose